Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
12/2003
12/04/2003WO1999013818A3 Membrane virus host range mutations and their uses as vaccine substrates
12/04/2003US20030226155 Modified transferrin-antibody fusion proteins
12/04/2003US20030225017 Chlamydia antigens and corresponding DNA fragments and uses thereof
12/04/2003US20030224982 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
12/04/2003US20030224980 Diagnostic reagents for human cytomegalovirus and methods of use
12/04/2003US20030224487 Novel cytokine zcytor17 ligand
12/04/2003US20030224476 Enhancing transglutaminase reactivity for use in food processing and flavor improvement
12/04/2003US20030224443 Novel epithelial tissue imaging agent
12/04/2003US20030224414 Comprises nucleotide sequences coding enzymatic polypeptide for diagnosis, prognosis and treatment of cell proliferative disorders
12/04/2003US20030224413 Comprises polynucleotides coding restriction fragment length polymorphism for use in identifying, characterizing and treatment of blood, respiratory, tumor and nervous system disorders
12/04/2003US20030224392 Detecting aberrant nucleic acids or peptides of urogenital system for use in treating cancers and preventing infections; genetic vaccines
12/04/2003US20030224376 Novel human transferase family members and uses thereof
12/04/2003US20030224352 Comprises lymphadenopathy viral sequences for diagnosis of aquired immuno-depressive syndromes
12/04/2003US20030224037 An antitumor agent oxaliplatin in transferrins liposome ligand and polyoxyethylene glycol, improving the storage stability, detoxifying and inhibiting the side effect caused by therapeutic drug
12/04/2003US20030224036 Containing epitope polypeptides, amino acid sequences, a immunotherapy for treating cancer; cancer vaccines
12/04/2003US20030224021 Methods of using epitope peptides of human pathogens
12/04/2003US20030224019 Administering a therapeutically effective amount of Botulinum toxin type B to a patient suffering from nerve entrapment syndrome ( carpal tunnel syndrome, piriformis syndrome, cubital tunnel syndrome, and radial tunnel syndrome)
12/04/2003US20030224018 Modified Vaccinia Virus Ankara for the vaccination of neonates
12/04/2003US20030224016 Transport peptides such as C-terminal Erns peptide and analogues thereof
12/04/2003US20030224015 Administering to a mammal an immunogenic formulation containing an Ebola peptide, to induce a protective cytotoxic T lymphocyte response
12/04/2003US20030224013 Methods for protection against Coccidioides spp. infection using Coccidioides spp. urea amidohydrolase (Ure) protein
12/04/2003US20030224012 Identifying a BASB033 polypeptide or an antibody that is immunospecific for such polypeptide, present with in a biological sample form the animal suspected having meningococcus induced infections and meningitis
12/04/2003US20030224011 A polypeptide or protein complex carrier and one or more HCV (Hepatitis C virus) mimotopes to provide antigens able to generate antibodies for recognizing the hypervariable region of HCV E2 protein
12/04/2003US20030224010 Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
12/04/2003US20030224007 A protective protein in the form of vaccine, containing a polypeptide from a pro-region of a cathepsin L protease obtained from excretory/secretory products of newly excysted juvenile stages of Fasciola hepatical
12/04/2003US20030224005 Applying a formulation containing interferon gamma antibodies topically to the eye to treat hyperimmune reactions, such as transplant rejection, autoimmune diseases of the eye and ocular disorders connected with autoimmune diseases
12/04/2003US20030224004 Chlamydia antigens and corresponding DNA fragments and uses thereof
12/04/2003US20030224003 Administering to a mammal a preparation containing a portion of the amino acid sequence of mature adenylate cyclase of a second Bordetella species for immunizing the mammal against infection by a first Bordetella species
12/04/2003US20030224000 Methods for blocking or alleviating staphylococcal nasal colonization by intranasal application of monoclonal antibodies
12/04/2003US20030223999 Use of trifunctional bispecific and trispecific antibodies for the treatment of malignant ascites
12/04/2003US20030223997 Nucleic acid and corresponding protein entitled 121P1F1 useful in treatment and detection of cancer
12/04/2003US20030223995 Treatment of pemphigus vulgaris
12/04/2003US20030223994 Protein ligands comprising an immunoglobulin heavy chain variable (VH) domain and an immunoglobulin light chain variable (VL) domain, wherein the proteins bind a complex comprising an MHC and a peptide, do not substantially bind the
12/04/2003US20030223992 G-protein coupled receptor ligands and methods
12/04/2003US20030223991 Modulating activity of the immune system using agonists or antagonists of a CD200 receptor. Also provided are methods of treatment and diagnosis of immune disorders.
12/04/2003US20030223990 A novel gene (designated 193P1E1B) and its encoded protein, and variants thereof, are described wherein 193P1E1B exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in the cancers. 193P1E1 provides
12/04/2003US20030223987 Immunodeficiency recombinant poxvirus
12/04/2003US20030223973 Discloses the protease stratum corneum chymotrytic enzyme (SCCE) is specifically over-expressed in ovarian and other malignancies. A number of SCCE peptides can induce immune responses to SCCE, thereby demonstrating the potential of
12/04/2003US20030223964 Efficient expression of HIV polypeptides in a variety of cell types, including, but not limited to, mammalian, insect, and plant cells. Synthetic expression cassettes encoding the HIV Gag-containing polypeptides are described, as are uses of the
12/04/2003US20030223961 Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof
12/04/2003US20030222461 Anti-panic opening system for doors
12/04/2003US20030221931 Sliding device
12/04/2003DE20310413U1 Vaccine, useful for treatment or prevention of infections or tumors, produced by inactivation with ultra-violet B radiation, retains antigenic structures while damaging nucleic acid
12/04/2003CA2704273A1 Mn/ca ix-antibody binding specifically to non-immunodominant epitope of mn/ca ix and uses thereof
12/04/2003CA2487452A1 A method for generating antigen-presenting cells
12/04/2003CA2487441A1 Novel uses of parapoxvirus preparations
12/04/2003CA2486918A1 Novel chimeric cd154
12/04/2003CA2486621A1 Induction and maintenance of tolerance to composite tissue allografts
12/04/2003CA2486620A1 Chimeric allograft tolerance induction, monitoring and maintenance
12/04/2003CA2486618A1 Methods for the in vitro culture of sporozoea sp. and uses thereof
12/04/2003CA2485816A1 Vaccines
12/04/2003CA2485733A1 Vaccines
12/04/2003CA2484000A1 Neutralizing human anti-igfr antibody
12/04/2003CA2483627A1 Mitotic kinesin inhibitors
12/04/2003CA2478833A1 Anti-.alpha.v.beta.6 antibodies
12/03/2003EP1367123A1 Neurotonin and use thereof
12/03/2003EP1366769A1 Inhibition of lymphocyte adherence to vascular endothelium utilizing extracellular matrix receptor-ligand interaction
12/03/2003EP1366366A2 Compositions and methods for the diagnosis, treatment and prevention of steroid hormone responsive cancers
12/03/2003EP1366363A1 Methods for immuno-detection of epitopes on molecules and for detection of interactions of molecules via fluorescent dyes
12/03/2003EP1366171A2 Replication-competent molecular clones of porcine endogenous retrovirus class a and class b derived from pig and human cells
12/03/2003EP1366170A1 Use of flavivirus for the expression of protein epitopes and development of new live attenuated vaccine virus to immune against flavivirus and other infectious agents
12/03/2003EP1366169A2 Antigenic proteins of shrimp white spot syndrome virus and uses thereof
12/03/2003EP1366167A2 Biological organism for preparing pharmaceutical compositions for treating mammals
12/03/2003EP1366162A2 Putative proteins and nucleic acids encoding same
12/03/2003EP1366161A2 Interleukin-8 homologous polypeptides and therapeutic uses thereof
12/03/2003EP1366158A2 Trp8, trp9 and trp10, markers for cancer
12/03/2003EP1366157A2 Compositions and methods for the therapy and diagnosis of lung cancer
12/03/2003EP1366153A2 Compositions and methods for the therapy and diagnosis of her-2/neu-associated malignancies
12/03/2003EP1366150A2 Use of protein histidine phosphatase
12/03/2003EP1366080A1 Natural antibodie active against hiv virus
12/03/2003EP1366079A2 Nuclear hormone receptor ligand binding domain
12/03/2003EP1366068A1 Poynucleotide and polypeptide from group b streptococcus and use thereof for the preparation of a vaccine
12/03/2003EP1365804A2 Histidine proline rich glycoprotein (hprg) as an anti-angiogenic and anti-tumor agent
12/03/2003EP1365803A2 Chemoprotectant for gastric toxicity
12/03/2003EP1365802A2 Salmonella promoter for heterologous gene expression
12/03/2003EP1365797A2 Methods and agents modulating upa/upar activity
12/03/2003EP1365780A2 Immune response potentiation
12/03/2003EP1365774A2 Use of zwitterionic polysaccharides for the specific modulation of immune processes
12/03/2003EP1246634B1 Neurotoxins for treating pancreatic disorders
12/03/2003EP1115427B1 Time-staggered utilization of tumor cells in combination with intact antibodies for immunization
12/03/2003EP1037643B1 Cancer immunotherapy using allostimulated cells in a multiple sequential implantation strategy
12/03/2003EP0996464B1 Multivalent in ovo avian vaccine
12/03/2003EP0952982B1 Novel hepatitis b inhibitors
12/03/2003EP0687295B1 Human b-lymphoblastoid cell line secreting anti-ganglioside antibody
12/03/2003CN1460111A HIV peptides from conserved regions in GAGP 17 and 924 and their application in e.g. vaccines
12/03/2003CN1460025A Immunomodulatory human MHC class Ôàí antigen-binding polypeptides
12/03/2003CN1129796C Medicine box for detecting hepatitis virus C and use thereof
12/03/2003CN1129795C Methods of typing hepatitis C virus and reagents for use therein
12/03/2003CN1129454C DNA vaccine for foot and mouth disease
12/03/2003CN1129453C Mycobacterium vaccae for down regulation of Th2 activity of immune system
12/03/2003CA2409795A1 Liposome preparation
12/02/2003US6657104 Cell-based, and whole-animal-based assays for detecting substances having therapeutic activity toward cardiac hypertrophy.
12/02/2003US6657056 Compounds for immunotherapy of prostate cancer and methods for their use
12/02/2003US6657047 Nucleotide sequences coding polypeptide for use in the treatment of tumors, inflammation, psoriasis, rheumatoid arthritis, cardiovascular and vision disorders
12/02/2003US6656720 For use in vaccines
12/02/2003US6656719 Serum-free, low-protein media for rotavirus vaccine production
12/02/2003US6656714 Protein for use in the immunotherapy and nutrient mixtures
12/02/2003US6656713 Compounds and methods for modulating activation of NF-κB
12/02/2003US6656707 Nucleic acid molecules encoding the same; vectors, host cells, pharmaceutical compositions, selective binding agents and methods for production; antagonists and agonists; bactericides; viricides
12/02/2003US6656706 Molecular clones with mutated HIV gag/pol, SIV gag and SIV env genes
1 ... 1191 1192 1193 1194 1195 1196 1197 1198 1199 1200 1201 1202 1203 1204 1205 1206 1207 1208 1209 1210 1211 ... 1823